Pelong, Diosdado B.

HRN: 07-15-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/13/2023
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
04/13/2023
04/20/2023
TOPICAL
Apply Generously To Affected Site
BID
Heat Rash
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: